Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04501276 |
| Title | A Phase 1b Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Adagene Inc |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Next Oncology | San Antonio | Texas | 78229 | United States | Details | |
| Ashford Cancer Centre Research | Kurralta Park | Australia | Details | |||
| Cabrini Hospital | Malvern | Australia | Details | |||
| Macquarie University | Sydney | Australia | Details |